Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.79%11.65M | 13.14%11.25M | -1.32%9.41M | -10.34%39.4M | 10.04M | 9.89M | 9.94M | 9.53M | 65.53%43.95M | 30.69%26.55M |
| Cost of revenue | 26.34%5.32M | 3.57%5.34M | 39.95%5.1M | -19.97%17.19M | 4.18M | 4.21M | 5.16M | 3.64M | 130.63%21.48M | -20.84%9.32M |
| Gross profit | 11.45%6.33M | 23.45%5.91M | -26.84%4.31M | -1.14%22.21M | 5.86M | 5.68M | 4.78M | 5.89M | 30.34%22.46M | 101.64%17.23M |
| Operating expense | -20.51%3.73M | 6.01%3.79M | 23.61%4.01M | 21.15%13.73M | 3.12M | 4.69M | 3.58M | 3.25M | 45.87%11.34M | 36.24%7.77M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 39.68%3.7M |
| Selling and administrative expenses | -27.16%2.85M | 1.04%2.91M | 27.07%3.23M | 36.41%11.69M | --2.35M | --3.91M | --2.88M | --2.55M | 450.64%8.57M | 32.65%1.56M |
| -Selling and marketing expense | 38.15%507K | 10.59%376K | 15.86%453K | -38.23%1.16M | --62K | --367K | --340K | --391K | 164.50%1.88M | 47.41%712K |
| -General and administrative expense | -33.92%2.34M | -0.24%2.54M | 29.11%2.78M | 57.44%10.52M | --2.29M | --3.55M | --2.54M | --2.15M | 692.03%6.68M | 22.32%844K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 11.73%2.51M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 11.73%2.51M |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2K |
| Other operating expenses | 13.00%878K | 26.62%880K | 11.00%777K | 2.70%2.95M | --775K | --777K | --695K | --700K | 8,093.18%2.87M | -12.50%35K |
| Total other operating income | ---- | ---- | ---- | 800.00%900K | ---- | ---- | ---- | ---- | 334.78%100K | -94.21%23K |
| Operating profit | 163.49%2.6M | 75.14%2.11M | -88.70%299K | -23.84%8.47M | 2.73M | 986K | 1.21M | 2.65M | 17.58%11.13M | 232.85%9.46M |
| Net non-operating interest income (expenses) | -325.00%-117K | 67.82%-65K | 7.11%-209K | 53.99%-534.11K | -111K | 52K | -202K | -225K | -5.91%-1.16M | 11.61%-1.1M |
| Non-operating interest income | -68.75%70K | 300.00%132K | 527.27%69K | 1,361.92%359.14K | --138K | --224K | --33K | --11K | -49.87%24.57K | -43.02%49K |
| Non-operating interest expense | 8.72%187K | -16.17%197K | 17.80%278K | -24.64%893.24K | --249K | --172K | --235K | --236K | 3.52%1.19M | -13.65%1.15M |
| Net investment income | -81.24%4.13K | 15.79%22K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 354.04K | 0 | -318.66%-750K | |||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Less:Other special charges | ---- | ---- | ---- | ---4.04K | ---- | ---- | ---- | ---- | ---- | 30.90%-237K |
| Less:Write off | ---- | ---- | ---- | ---350K | ---- | ---- | ---- | ---- | --0 | --987K |
| Other non-operating income (expenses) | -89.27%28K | -64.92%181K | -13.44%50.08K | 222K | 261K | 259K | 516K | -84.11%57.85K | 3,540.00%364K | |
| Income before tax | 93.15%2.51M | 62.10%2.05M | -90.77%271K | -16.79%8.34M | 2.84M | 1.3M | 1.26M | 2.94M | 25.30%10.03M | 305.22%8M |
| Income tax | 202.59%702K | 54.81%596K | -89.61%88K | -6.75%2.74M | 1.28M | 232K | 385K | 847K | 51.20%2.94M | 556.81%1.95M |
| Net income | 69.35%1.81M | 65.30%1.45M | -91.24%183K | -20.96%5.6M | 1.56M | 1.07M | 879K | 2.09M | 16.98%7.09M | 152.27%6.06M |
| Net income continuous operations | 69.35%1.81M | 65.30%1.45M | -91.24%183K | -20.96%5.6M | --1.56M | --1.07M | --879K | --2.09M | 16.98%7.09M | 152.27%6.06M |
| Noncontrolling interests | 0 | |||||||||
| Net income attributable to the company | 69.35%1.81M | 65.30%1.45M | -91.24%183K | -20.96%5.6M | 1.56M | 1.07M | 879K | 2.09M | 16.98%7.09M | 151.85%6.06M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 69.35%1.81M | 65.30%1.45M | -91.24%183K | -20.96%5.6M | 1.56M | 1.07M | 879K | 2.09M | 16.98%7.09M | 151.85%6.06M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 66.67%0.0045 | 20.00%0.0036 | 856.94%0.05 | -42.14%0.014 | 0.0039 | 0.0027 | 0.003 | 0.0052 | 59.79%0.0242 | 151.84%0.0151 |
| Diluted earnings per share | 66.67%0.0045 | 63.64%0.0036 | 856.94%0.05 | -20.97%0.014 | 0.0039 | 0.0027 | 0.0022 | 0.0052 | 16.98%0.0177 | 151.84%0.0151 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.